Cilgavimab/Tixagevimab as alternative therapeutic approach for BA.2 infections.
Dichtl S, Zaderer V, Kozubowski V, Abd El Halim H, Lafon E, Lanser L, Weiss G, Lass-Flörl C, Wilflingseder D, Posch W.
Dichtl S, et al.
Front Med (Lausanne). 2022 Sep 29;9:1005589. doi: 10.3389/fmed.2022.1005589. eCollection 2022.
Front Med (Lausanne). 2022.
PMID: 36250084
Free PMC article.